{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:12:35Z","timestamp":1782151955424,"version":"3.54.5"},"reference-count":40,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Apart from the well-known fact that hyperthyroidism induces multiple prothrombotic disorders, there is no consensus in clinical practice as to the impact of hyperthyroidism on the risk of thrombosis. The aim of this study was to examine the various hemostatic and immunologic parameters in patients with hyperthyroidism. Methods: Our study consists of a total of 200 patients comprised of 64 hyperthyroid patients, 68 hypothyroid patients, and 68 euthyroid controls. Patient thyroid status was determined with standard tests. Detailed hemostatic parameters and cardiolipin antibodies of each patient were determined. Results: The values of factor VIII (FVIII), the Von Willebrand factor (vWF), fibrinogen, plasminogen activator inhibitor-1 (PAI-1), and anticardiolipin antibodies of the IgM class were significantly higher in the hyperthyroid patients than in the hypothyroid patients and euthyroid controls. The rate of thromboembolic manifestations was much higher in hyperthyroid patients (6.25%) than in hypo-thyroid patients (2.9%) and euthyroid controls (1.4%). Among hyperthyroid patients with an FVIII value of \u22651.50 U\/mL, thrombosis was recorded in 8.3%, while in hyperthyroid patients with FVIII value \u2264 1.50 U\/mL the occurrence of thrombosis was not recorded. The incidence of atrial fibrillation (AF) was significantly higher (8.3%) in the hyperthyroid patients compared to the hypothyroid patients (1.5%) and euthyroid controls (0%). Conclusions: High levels of FVIII, vWF, fibrinogen, PAI-1, and anticardiolipin antibodies along with other hemostatic factors contribute to the presence of a hypercoaguable state in patients with hyperthyroidism. The risk of occurrence of thrombotic complications is especially pronounced in patients with a level of FVIII exceeding 150% and positive anticardiolipin antibodies of the IgM class. Patients with AF are at particularly high risk of thrombotic complications due to a hyperthyroid prothrombotic milieu.<\/jats:p>","DOI":"10.3390\/jcm13061756","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T04:36:31Z","timestamp":1710822991000},"page":"1756","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Influence of Hyperthyroidism on the Coagulation and on the Risk of Thrombosis"],"prefix":"10.3390","volume":"13","author":[{"given":"Nebojsa","family":"Antonijevic","sequence":"first","affiliation":[{"name":"Clinic for Cardiology, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5982-4050","authenticated-orcid":false,"given":"Dragan","family":"Matic","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Beleslin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia"},{"name":"Clinic for Endocrinology, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Mikovic","sequence":"additional","affiliation":[{"name":"Blood Transfusion Institute of Serbia, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaklina","family":"Lekovic","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Marjanovic","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1484-9577","authenticated-orcid":false,"given":"Ana","family":"Uscumlic","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubica","family":"Birovljev","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branko","family":"Jakovljevic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia"},{"name":"Institute for Hygiene and Medical Ecology, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e33301","DOI":"10.1097\/MD.0000000000033301","article-title":"Association between thyroid dysfunction and venous thromboembolism: A systematic review and meta-analysis","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jth.13970","article-title":"The influence of thyroid function on the coagulation system and its clinical consequences","volume":"16","author":"Elbers","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1160\/TH12-07-0496","article-title":"The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: A systematic review and meta-analysis","volume":"108","author":"Stuijver","year":"2012","journal-title":"Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/jth.12573","article-title":"High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: The MEGA study","volume":"12","author":"Debeij","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1177\/1076029618774150","article-title":"New Interfaces of Thyroid Hormone Actions with Blood Coagulation and Thrombosis","volume":"24","author":"Davis","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: Full Text: A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"8","author":"Fuster","year":"2006","journal-title":"Europace"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"ref_8","first-page":"225","article-title":"Embolic risk in atrial fibrillation that arises from hyperthyroidism: Review of the medical literature","volume":"38","author":"Traube","year":"2011","journal-title":"Tex. Heart Inst. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.21.1.4","article-title":"Thromboembolic complications in atrial fibrillation","volume":"21","author":"Petersen","year":"1990","journal-title":"Stroke"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fendo.2017.00175","article-title":"Thyroid Autoimmunity and Antiphospholipid Syndrome: Not Such a Trivial Association","volume":"8","author":"Versini","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_11","unstructured":"Bithell, T.C. (1993). Wintrobe\u2019s Clinical Hematology, Lee R.G. Lea & Febiger."},{"key":"ref_12","unstructured":"Bithell, T.C. (1993). Wintrobe\u2019s Clinical Hematology, Lee R.G. Lea & Febiger."},{"key":"ref_13","first-page":"43","article-title":"Problems of anticoagulation with warfarin in hyperthyroidism","volume":"225","author":"Kellett","year":"1986","journal-title":"Q. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1210\/jc.2004-0536","article-title":"Is thyroid hormone suppression therapy prothrombotic?","volume":"89","author":"Horne","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.ATV.19.7.1776","article-title":"The relationship of fibrinogen and factor VII and VIII to incident cardiovascular disease and death in the elderly: Result from the cardiovascular health study","volume":"19","author":"Tracy","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/archinte.1984.00350130143025","article-title":"Unusual Manifestation of hypothyroidism","volume":"144","author":"Klein","year":"1984","journal-title":"Arch. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1046\/j.1365-2362.1998.00381.x","article-title":"Impaired release of tissue plasminogen activator from the endothelium in Graves\u2019 disease-indicator of endothelial dysfunction and reduced fibrinolytic capacity","volume":"28","author":"Li","year":"1998","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1210\/jc.2006-2644","article-title":"Altered platelet plug formation in hyperthyroidism and hypothyroidism","volume":"92","author":"Homoncik","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/01.CIR.98.21.2241","article-title":"High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women. Evidence for the fibrinolytic system as an independent primary risk factor","volume":"98","author":"Jansson","year":"1998","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris","volume":"332","author":"Thompson","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_21","unstructured":"Hoffman, A., Benz, E.J., Shattil, S.J., Furie, B., Cohen, J.H., and Silberstein, L.E. (1995). Hematology; Basic Principles and Practice, Churchill Livingstone. [2nd ed.]."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0735-1097(99)00007-8","article-title":"A prospective study of fibrinogen and risk of myocardial infarction in the physicians Health study","volume":"33","author":"Ma","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/jc.2004-1554","article-title":"The association of thyroid function with cardiac mass and left ventricular hypertrophy","volume":"90","author":"Wolf","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","unstructured":"Goodnight, S.H., and Hathaway, W.E. (2001). Disorders of Haemostasis and Thrombosis, The McGraw-Hill Companies."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1210\/jc.2007-0199","article-title":"Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review","volume":"92","author":"Squizzato","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","unstructured":"Goodnight, S.H., and Hathaway, W.E. (2001). Disorders of Haemostasis and Thrombosis, The McGraw-Hill Companies."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","article-title":"Plasminogen-activator inhibitor type 1 and coronary artery disease","volume":"342","author":"Kohler","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1055\/s-0037-1613305","article-title":"Association between increases homocysteine levels and impaired fibrinolytic potential: Potential mechanism for cardiovascular risk","volume":"88","author":"Tofler","year":"2002","journal-title":"Thromb. Haemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","article-title":"Plasminogen activator inhibitors in plasma: Risk factor for recurrent myocardial infarction","volume":"8549","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"key":"ref_30","unstructured":"Hoffman, R., Benz, E.J., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E., and McGlave, P. (2005). Hematology: Basic Principles and Practice, Elsevier Churchill Livingstone."},{"key":"ref_31","unstructured":"Colman, R.W., Clowes, A.W., Goldhaber, S.Z., Marder, V.J., and George, J.N. (2006). Haemostasis and Thrombosis: Basic Principles and Clinical Practice, Lippincott Williams&Wilkins."},{"key":"ref_32","unstructured":"Colman, R.W., Hirsh, J., Marder, V.J., Clowes, A.W., and George, J.N. (2001). Haemostasis and Thrombosis: Basic Principles and Clinical Practice, Lippincott Williams&Wilkins."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.STR.19.1.15","article-title":"Stroke in thyrotoxicosis with atrial fibrilation","volume":"19","author":"Petersen","year":"1989","journal-title":"Stroke"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/STROKEAHA.109.577742","article-title":"Hyperthyroidism and risk of ischemic stroke in young adults: A 5-year follow-up study","volume":"5","author":"Sheu","year":"2010","journal-title":"Stroke"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bmj.2.6088.688","article-title":"Arterial embolism in thyrotoxicosis with atrial fibrillation","volume":"2","author":"Staffurth","year":"1977","journal-title":"Br. Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(73)92019-9","article-title":"Death from thyrotoxicosis","volume":"2","author":"Parker","year":"1973","journal-title":"Lancet"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrothropin result: A 10-year cohort study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.hrthm.2008.10.023","article-title":"Risk of ischemic stroke after new-onset atrial fibrillation in patients with hyperthyroidism","volume":"6","author":"Siu","year":"2009","journal-title":"Heart Rhythm"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jth.14343","article-title":"High levels of coagulation factors and venous thrombosis risk: Strongest association for factor VIII and von Willebrand factor","volume":"17","author":"Rietveld","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/j.1538-7836.2010.03993.x","article-title":"Increased risk of pulmonary embolism among patients with hyperthyroidism: A 5-year follow-up study","volume":"8","author":"Lin","year":"2010","journal-title":"J. Thromb. Haemost."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/6\/1756\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:15:40Z","timestamp":1760105740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/6\/1756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["jcm13061756"],"URL":"https:\/\/doi.org\/10.3390\/jcm13061756","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]}}}